Fin Breatnach

936 total citations
26 papers, 571 citations indexed

About

Fin Breatnach is a scholar working on Neurology, Pediatrics, Perinatology and Child Health and Surgery. According to data from OpenAlex, Fin Breatnach has authored 26 papers receiving a total of 571 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 6 papers in Pediatrics, Perinatology and Child Health and 5 papers in Surgery. Recurrent topics in Fin Breatnach's work include Neuroblastoma Research and Treatments (7 papers), Cancer therapeutics and mechanisms (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). Fin Breatnach is often cited by papers focused on Neuroblastoma Research and Treatments (7 papers), Cancer therapeutics and mechanisms (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). Fin Breatnach collaborates with scholars based in Ireland, United States and United Kingdom. Fin Breatnach's co-authors include Anne O’Meara, Michael McDermott, Raymond L. Stallings, A. O’Meara, Daniel Catchpoole, Prakash Nair, John M. Maris, M. S. Quraishi, A. W. Blayney and Aengus O’Marcaigh and has published in prestigious journals such as Cancer Research, The Journal of Urology and British Journal of Haematology.

In The Last Decade

Fin Breatnach

26 papers receiving 558 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fin Breatnach Ireland 13 127 122 118 109 101 26 571
Edythe A. Albano United States 13 202 1.6× 74 0.6× 110 0.9× 230 2.1× 119 1.2× 24 714
Moussab Damlaj Saudi Arabia 13 136 1.1× 101 0.8× 91 0.8× 67 0.6× 67 0.7× 65 625
Leslie M. Taylor United States 9 66 0.5× 71 0.6× 42 0.4× 99 0.9× 140 1.4× 16 465
Janet Poole South Africa 14 153 1.2× 62 0.5× 32 0.3× 116 1.1× 100 1.0× 29 612
Rob Newton United Kingdom 14 156 1.2× 56 0.5× 37 0.3× 51 0.5× 55 0.5× 28 593
H Hägglund Sweden 20 340 2.7× 48 0.4× 50 0.4× 153 1.4× 97 1.0× 34 1.0k
Angela MacCarthy United Kingdom 13 132 1.0× 85 0.7× 46 0.4× 98 0.9× 92 0.9× 19 661
Tulio E. Rodriguez United States 14 223 1.8× 80 0.7× 38 0.3× 70 0.6× 54 0.5× 53 724
Vijay Gandhi Linga India 14 118 0.9× 112 0.9× 24 0.2× 110 1.0× 78 0.8× 45 620
S O Lie Norway 9 83 0.7× 87 0.7× 89 0.8× 193 1.8× 149 1.5× 14 487

Countries citing papers authored by Fin Breatnach

Since Specialization
Citations

This map shows the geographic impact of Fin Breatnach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fin Breatnach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fin Breatnach more than expected).

Fields of papers citing papers by Fin Breatnach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fin Breatnach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fin Breatnach. The network helps show where Fin Breatnach may publish in the future.

Co-authorship network of co-authors of Fin Breatnach

This figure shows the co-authorship network connecting the top 25 collaborators of Fin Breatnach. A scholar is included among the top collaborators of Fin Breatnach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fin Breatnach. Fin Breatnach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Breatnach, Fin, et al.. (2008). Cytomegalovirus infection in paediatric haemopoietic stem cell transplantation.. PubMed. 101(1). 17–21. 4 indexed citations
2.
Ryan, Jacqueline, Fiona Quinn, Ludmila Boublíková, et al.. (2008). Minimal residual disease detection in childhood acute lymphoblastic leukaemia patients at multiple time‐points reveals high levels of concordance between molecular and immunophenotypic approaches. British Journal of Haematology. 144(1). 107–115. 42 indexed citations
3.
Mortell, Alan, et al.. (2007). Penile Malignant Peripheral Nerve Sheath Tumour (Schwannoma) in a Three-Year-Old Child without Evidence of Neurofibromatosis. European Journal of Pediatric Surgery. 17(6). 428–430. 8 indexed citations
4.
Stallings, Raymond L., Prakash Nair, John M. Maris, et al.. (2006). High-Resolution Analysis of Chromosomal Breakpoints and Genomic Instability Identifies PTPRD as a Candidate Tumor Suppressor Gene in Neuroblastoma. Cancer Research. 66(7). 3673–3680. 97 indexed citations
5.
Stallings, Raymond L., et al.. (2004). Molecular cytogenetic analysis of recurrent unbalanced t(11;17) in neuroblastoma. Cancer Genetics and Cytogenetics. 154(1). 44–51. 14 indexed citations
6.
Stallings, Raymond L., M. Mullarkey, Michael McDermott, et al.. (2004). Evolution of unbalanced gain of distal chromosome 2p in neuroblastoma. Cytogenetic and Genome Research. 106(1). 49–54. 10 indexed citations
7.
Stallings, R.L., Julie Howard, M. Mullarkey, et al.. (2003). Are gains of chromosomal regions 7q and 11p important abnormalities in neuroblastoma?. Cancer Genetics and Cytogenetics. 140(2). 133–137. 28 indexed citations
8.
McNally, Paul, Fin Breatnach, Aengus O’Marcaigh, et al.. (2001). Potentiation of vincristine toxicity by itraconazole in children with lymphoid malignancies. Acta Paediatrica. 90(10). 1204–1207. 44 indexed citations
9.
McNally, Paul, Fin Breatnach, David Webb, et al.. (2001). Potentiation of vincristine toxicity by itraconazole in children with lymphoid malignancies. Acta Paediatrica. 90(10). 1204–1207. 12 indexed citations
10.
Rice, Michael, et al.. (2000). COMPARATIVE GENOMIC HYBRIDIZATION IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA. Pediatric Hematology and Oncology. 17(2). 141–147. 3 indexed citations
11.
Mabro, May, R Cohn, L Zanesco, et al.. (2000). [Oral granisetron solution as prophylaxis for chemotherapy-induced emesis in children: double-blind study of 2 doses].. PubMed. 87(3). 259–64. 9 indexed citations
12.
Nourse, Clare, Holly Murphy, Catherine Byrne, et al.. (1998). Control of a nosocomial outbreak of vancomycin resistant Enterococcus faecium in a paediatric oncology unit: risk factors for colonisation. European Journal of Pediatrics. 157(1). 20–27. 52 indexed citations
13.
McCarthy, Robert J., et al.. (1997). Central venous catheter infections treated with teicoplanin. European Journal Of Haematology. 59(S62). 15–17. 10 indexed citations
14.
Quraishi, M. S., et al.. (1995). Langerhans' cell histiocytosis: Head and neck manifestations in children. Head & Neck. 17(3). 226–231. 29 indexed citations
15.
Quraishi, M. S., A. W. Blayney, & Fin Breatnach. (1993). Aural symptoms as primary presentation of Langerhan's cell histiocytosis. Clinical Otolaryngology. 18(4). 317–323. 16 indexed citations
16.
O’Meara, A., et al.. (1992). A new approach to the management of Broviac catheter infection. Journal of Hospital Infection. 22(2). 109–116. 37 indexed citations
17.
Gururangan, S., et al.. (1992). Primary hepatic tumours in children: A 26—year review. Journal of Surgical Oncology. 50(1). 30–36. 25 indexed citations
18.
Connolly, Bairbre, Anthony Staines, Anne O’Meara, Fin Breatnach, & R.J. Fitzgerald. (1992). The Changing Role of Surgery in the Management of Rhabdomyosarcoma. European Journal of Pediatric Surgery. 2(2). 90–93. 1 indexed citations
19.
Leavey, Patrick J., Marie Varughese, Fin Breatnach, & A. O’Meara. (1991). Langerhans cell histiocytosis — a 31 year review. Irish Journal of Medical Science (1971 -). 160(9). 271–274. 9 indexed citations
20.
Kemshead, J. T., L. S. Lashford, Jeffrey W. Prichard, et al.. (1986). 131-I Coupled to Monoclonal Antibodies as Therapeutic Agents for Neuroectodermally Derived Tumors: Fact or Fiction?. PubMed. 3(1). 25–43. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edythe A. Albano Breakdown of academic impact, for papers by Moussab Damlaj Breakdown of academic impact, for papers by Leslie M. Taylor Breakdown of academic impact, for papers by Janet Poole Breakdown of academic impact, for papers by Rob Newton Breakdown of academic impact, for papers by H Hägglund Breakdown of academic impact, for papers by Angela MacCarthy Breakdown of academic impact, for papers by Tulio E. Rodriguez Breakdown of academic impact, for papers by Vijay Gandhi Linga Breakdown of academic impact, for papers by S O Lie
Rankless by CCL
2026